{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:07:55Z","timestamp":1787969275094,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1053\/plac.2002.0843","type":"journal-article","created":{"date-parts":[[2002,8,26]],"date-time":"2002-08-26T21:02:18Z","timestamp":1030395738000},"page":"547-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Apoptotic Activity in Villous Trophoblast Cells During B19 Infection Correlates with Clinical Outcome: Assessment by the Caspase-related M30 CytoDeath Antibody"],"prefix":"10.1016","volume":"23","author":[{"given":"J.A.","family":"Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Butchko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/plac.2002.0843_RF1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0022172400060964","article-title":"An outbreak of erythema infectiosum associated with human parvovirus B19 infection","volume":"93","author":"Anderson","year":"1984","journal-title":"J Hyg (Lond)"},{"key":"10.1053\/plac.2002.0843_RF2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.8211117","article-title":"Erythrocyte P antigen: Cellular receptor for B19 parvovirus","volume":"262","author":"Brown","year":"1993","journal-title":"Science"},{"key":"10.1053\/plac.2002.0843_RF3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(94)90011-6","article-title":"Congenital anaemia after transplacental B19 parvovirus infection","volume":"343","author":"Brown","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/plac.2002.0843_RF4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199404283301704","article-title":"Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen)","volume":"330","author":"Brown","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/plac.2002.0843_RF5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1083\/jcb.138.6.1379","article-title":"Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis","volume":"138","author":"Caulin","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1053\/plac.2002.0843_RF6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2559.2001.01065.x","article-title":"Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody","volume":"38","author":"Chiu","year":"2001","journal-title":"Histopathology"},{"key":"10.1053\/plac.2002.0843_RF7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jmv.1890230409","article-title":"Detection of parvovirus B19 DNA, antigen, and particles in the human fetus","volume":"23","author":"Clewley","year":"1987","journal-title":"J Med Virol"},{"key":"10.1053\/plac.2002.0843_RF8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/00222615-25-2-151","article-title":"The prevalence of antibody to human parvovirus B19 in England and Wales","volume":"25","author":"Cohen","year":"1988","journal-title":"Med Microbiol"},{"key":"10.1053\/plac.2002.0843_RF9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/ard.45.10.832","article-title":"Human parvovirus infection in early rheumatoid and inflammatory arthritis","volume":"45","author":"Cohen","year":"1986","journal-title":"Am Rheum Dis"},{"key":"10.1053\/plac.2002.0843_RF10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"i","author":"Cossart","year":"1975","journal-title":"Lancet"},{"key":"10.1053\/plac.2002.0843_RF11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/art.1780310218","article-title":"Human parvovirus B19 DNA in synovial fluid","volume":"31","author":"Dijkmans","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1053\/plac.2002.0843_RF12","first-page":"74","article-title":"Parvovirus B19 infections in pregnancy","volume":"85","author":"Enders","year":"1990","journal-title":"Behring Inst Mitt"},{"key":"10.1053\/plac.2002.0843_RF13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-113-12-926","article-title":"Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS","volume":"113","author":"Frickhofen","year":"1990","journal-title":"Am Intern Med"},{"key":"10.1053\/plac.2002.0843_RF14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9378(96)70370-8","article-title":"Identification of Human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis","volume":"174","author":"Jordan","year":"1996","journal-title":"Am J Obstet Gyn"},{"key":"10.1053\/plac.2002.0843_RF15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1128\/JCM.38.4.1472-1475.2000","article-title":"Comparison of a Baculovirus-derived undenatured VP2 antigen to an E. coli-derived VP1 antigen for detecting Human parvovirus B19 IgM and IgG in sera from pregnant women","volume":"38","author":"Jordan","year":"2000","journal-title":"J Clin Micro"},{"key":"10.1053\/plac.2002.0843_RF16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/plac.1998.0353","article-title":"Globoside expression within the human placenta","volume":"20","author":"Jordan","year":"1999","journal-title":"Placenta"},{"key":"10.1053\/plac.2002.0843_RF17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/CDLI.8.2.288-292.2001","article-title":"Placental cellular immune response in women infected with human parvovirus B19 during pregnancy","volume":"8","author":"Jordan","year":"2001","journal-title":"Clin Diagnos Lab Immunol"},{"key":"10.1053\/plac.2002.0843_RF18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/plac.2000.0616","article-title":"Expression of a cytokeratin 18 neo-epitope is a specific marker for trophoblast apoptosis in human placenta","volume":"22","author":"Kadyrov","year":"2001","journal-title":"Placenta"},{"key":"10.1053\/plac.2002.0843_RF19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/infdis\/157.4.663","article-title":"Risk of adverse outcomes of pregnancy after human parvovirus B19 infection","volume":"157","author":"Kinney","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1053\/plac.2002.0843_RF20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3476(05)82820-3","article-title":"Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients","volume":"116","author":"Koch","year":"1990","journal-title":"J Pediatr"},{"key":"10.1053\/plac.2002.0843_RF21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J","article-title":"Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis","volume":"187","author":"Leers","year":"1999","journal-title":"J Pathol"},{"key":"10.1053\/plac.2002.0843_RF22","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/JVI.72.4.3018-3028.1998","article-title":"Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells","volume":"72","author":"Moffatt","year":"1998","journal-title":"J Virol"},{"key":"10.1053\/plac.2002.0843_RF23","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1128\/jvi.68.12.8443-8446.1994","article-title":"A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity","volume":"68","author":"Momoeda","year":"1994","journal-title":"J Virol"},{"key":"10.1053\/plac.2002.0843_RF24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/path.1711690207","article-title":"Ultrastructual features of fetal erythroid precursors infected with parvovirus B19 in vitro: Evidence of cell death by apoptosis","volume":"169","author":"Morey","year":"1993","journal-title":"J Pathol"},{"key":"10.1053\/plac.2002.0843_RF25","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1471-0528.1992.tb13822.x","article-title":"Clinical and histopathological features of parvovirus B19 infection in the human fetus","volume":"99","author":"Morey","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1053\/plac.2002.0843_RF26","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1128\/JVI.75.16.7555-7563.2001","article-title":"Human parvovirus B19 induces cell cycle arrest at G2 phase with accumulation of mitotic cyclins","volume":"75","author":"Morita","year":"2001","journal-title":"J Virol"},{"key":"10.1053\/plac.2002.0843_RF27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/302426a0","article-title":"A human parvovirus-like virus inhibits haematopoietic colong formation in vitro","volume":"302","author":"Mortimer","year":"1983","journal-title":"Nature"},{"key":"10.1053\/plac.2002.0843_RF28","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/jvi.62.8.2884-2889.1988","article-title":"The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells","volume":"62","author":"Ozawa","year":"1988","journal-title":"J Virol"},{"key":"10.1053\/plac.2002.0843_RF29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jcp.41.4.381","article-title":"Parvovirus as a cause of hydrops fetalis: Detection by in situ DNA hybridization","volume":"41","author":"Porter","year":"1988","journal-title":"J Clin Pathol"},{"key":"10.1053\/plac.2002.0843_RF30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jcp.42.5.525","article-title":"Detection of parvovirus B19 DNA in fetal tissues by in situ hybridization and polymerase chain reaction","volume":"42","author":"Salimans","year":"1989","journal-title":"J Clin Pathol"},{"key":"10.1053\/plac.2002.0843_RF31","first-page":"83","article-title":"Murine experimental abortion by IL-2 administration is caused by activation of cytotoxic T lymphocytes and placental apoptosis","volume":"48","author":"Shiraishi","year":"1996","journal-title":"J Clin Lab Immunol"},{"key":"10.1053\/plac.2002.0843_RF32","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1128\/JVI.73.10.8762-8770.1999","article-title":"Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19","volume":"73","author":"Sol","year":"1999","journal-title":"J Virol"},{"key":"10.1053\/plac.2002.0843_RF33","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0140-6736(00)04647-X","article-title":"Frequency of human parvovirus B19 infection in intrauterine fetal death","volume":"357","author":"Tolfvenstam","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/plac.2002.0843_RF34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.1986.tb07492.x","article-title":"A murine monoclonal IgM antibody specific for blood group P antigen (globoside)","volume":"63","author":"Von dem Borne","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1053\/plac.2002.0843_RF35","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1128\/JVI.75.9.4110-4116.2001","article-title":"Recombinant human parvovirus B19 vectors: Erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells","volume":"75","author":"Weigel-Kelley","year":"2001","journal-title":"J Virol"},{"key":"10.1053\/plac.2002.0843_RF36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0163-4453(99)90105-6","article-title":"Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo","volume":"39","author":"Yaegashi","year":"1999","journal-title":"J Infect"},{"key":"10.1053\/plac.2002.0843_RF37","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1172\/JCI111625","article-title":"Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro","volume":"74","author":"Young","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1053\/plac.2002.0843_RF38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1534-5807(01)00031-4","article-title":"A viral phospholipase A2 is required for parvovirus infectivity","volume":"1","author":"Zadori","year":"2001","journal-title":"Developmental Cell"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014340040290843X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014340040290843X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:27:26Z","timestamp":1758907646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014340040290843X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S014340040290843X"],"URL":"https:\/\/doi.org\/10.1053\/plac.2002.0843","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apoptotic Activity in Villous Trophoblast Cells During B19 Infection Correlates with Clinical Outcome: Assessment by the Caspase-related M30 CytoDeath Antibody","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/plac.2002.0843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}